학술논문
SARS-CoV-2 Antibodies in Commercial Immunoglobulin Products Show Markedly Reduced Cross-reactivities Against Omicron Variants
Document Type
Artikel
Author
Source
Journal of clinical immunology. 43(6):1075-1082
Subject
Language
English
English
English
ISSN
1573-2592